Rfq 26-06-0080-01 Pr 26-06-0253 Albendazole 1,994,681.35 Tender
Notice for Rfq 26-06-0080-01 Pr 26-06-0253 Albendazole 1,994,681.35 Pharma in Philippines. The reference ID of the tender is 143512220 and it is closing on 25 Jun 2026.
Tender Details
- Country: Philippines
- Summary: Rfq 26-06-0080-01 Pr 26-06-0253 Albendazole 1,994,681.35 Pharma
- PHT Ref No: 143512220
- Deadline: 25 Jun 2026
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: PHP 1994681.35
- Notice Type: Tender
- Document Ref. No.: RFQ No. 26-06-0080-01
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Tender are invited for RFQ 26-06-0080-01 PR 26-06-0253 Albendazole 1,994,681.35 PHARMA
Product/Service Name : Albendazole 400 mg chewable tablet, Aluminum Hydroxide + Magnesium Hydroxide 200 mg al, Aluminum Hydroxide + Magnesium Hydroxide 225 mg al, Amlodipine (as besilate/camsylate) 5 mg tablet, Amlodipine (as besilate/camsylate) 10 mg tablet, Amoxicillin (as trihydrate) 250 mg capsule, Amoxicillin (as trihydrate) 500 mg capsule, Amoxicillin (as trihydrate) 100 mg/mL granules/pow, Amoxicillin (as trihydrate) 250 mg/5 mL granules, Co-Amoxiclav (amoxicillin + potassium clavulanate), Aspirin 80 mg tablet, Aspirin 100 mg tablet, Atenolol 50 mg tablet, Atenolol 100 mg tablet, Atorvastatin calcium 10 mg tablet, Atorvastatin calcium 20 mg tablet, Atorvastatin calcium 40 mg Tablet, Atorvastatin calcium 80 mg tablet, Azithromycin 500 mg (B) tablet (as base*/As dihydr, Azithromycin 200 mg/5 mL powder for suspension, 15, Budesonide + Formoterol Inhalation: DPI: 80 microg, Budesonide + Formoterol Inhalation: DPI: 160 micro, Budesonide + Formoterol Inhalation: DPI: 320 micro, Budesonide + Formoterol Inhalation: MDI: 80 microg, Budesonide + Formoterol Inhalation: MDI: 160 micro, Butamirate (as citrate) 50 mg MR tablet, Butamirate (as citrate) 7.5 mg/5 mL syrup, 120 mL, Captopril 25 mg tablet, Cefixime 200 mg capsule, Cefixime 400 mg capsule, Cefixime 20 mg/mL granules for drops (suspension),, Cefixime 100 mg/5 mL granules for suspension, 60 M, Cefuroxime 500 mg tablet (as axetil), Cef... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINRfq 26-06-0080-01 Pr 26-06-0253 Albendazole 1,994,681.35 Pharma - Philippines Tender
The ILOCOS SUR MEDICAL CENTER - CANDON CITY, ILOCOS SUR, a Government sector organization in Philippines, has announced a new tender for Rfq 26-06-0080-01 Pr 26-06-0253 Albendazole 1,994,681.35 Pharma. This tender is published on PhilippinesTenders under PHT Ref No: 143512220 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2026-06-25.
The estimated tender value is PHP 1994681.35, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
Fresh and verified Tenders from Philippines. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.
- 1,000+ Tenders
- Verified Tenders Only
- New Tenders Every Day
- Tenders Result Data
- Archive & Historical Tenders Access
- Consultants for RFI/RFP/RFQ
- Tender Notifications & Alerts
- Search, Sort, and Filter Tenders
- Bidding Assistance & Consulting
- Customer Support
- Publish your Tenders
- Export data to Excel
- API for Tender Data
- Tender Documents
Fill out the form below and you will receive a call from us within 24 hours.
Get FREE SAMPLE TENDERS from Philippines in your email inbox.
Copyright © 2014-2026 PhilippinesTenders.com. All Rights Reserved.


